Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.
about
Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity programHepatitis C virus infection and prisoners: Epidemiology, outcome and treatmentSocio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisonersHepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeThe societal cost of heroin use disorder in the United States.HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: a systematic review and meta-analysis.Predictors of reincarceration and disease progression among released HIV-infected inmatesThe contraceptive needs for STD protection among women in jail.An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners.Prison health in transitional Albania.Prevalence and correlates of hepatitis C virus infection among inmates at two New York State correctional facilities.Treatment, care and support for people co-infected with HIV and hepatitis C: a scoping review.Sofosbuvir-based treatment regimens for chronic, genotype 1 hepatitis C virus infection in U.S. incarcerated populations: a cost-effectiveness analysisPrevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.Incarceration, African Americans and HIV: advancing a research agenda.Incarceration is a major risk factor for blood-borne infection among intravenous drug users: Incarceration and blood borne infection among intravenous drug users.Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trialImpact of hepatitis B and C infection on health services utilization in homeless adults: a test of the Gelberg-Andersen Behavioral Model for Vulnerable Populations.Prevalence of HIV and Hepatitis B, C, D Infections and Their Associated Risk Factors among Prisoners in Southern Khorasan Province, Iran.A Cross-Sectional Study of Prisoners in Mexico City Comparing Prevalence of Transmissible Infections and Chronic Diseases with That in the General Population.Completion and subject loss within an intensive hepatitis vaccination intervention among homeless adults: the role of risk factors, demographics, and psychosocial variables.Prevalence of HIV and hepatitis C virus infections among inmates of Quebec provincial prisons.Prevalence of HIV, HepBsAg and Hep C antibodies among inmates in Chichiri prison, Blantyre, Malawi.HIV infection, viral hepatitis and liver fibrosis among prison inmates in West AfricaCommunity Wise: A formative evaluation of a community based health intervention.Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.Predictors of drug use in prison among incarcerated Black men.Chronic hepatitis B: current epidemiology in the Americas and implications for management.HIV/STI Risk Behavior of Drug Court Participants.From corrections to communities as an HIV priorityInfection control in jails and prisons.Hepatocellular carcinoma prevalence and mortality in a male state prison populationSeroprevalence of hepatitis B virus and human immunodeficiency virus among young prisonersTreating drug abuse and addiction in the criminal justice system: improving public health and safety.Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A.Treating hepatitis C in the prison population is cost-saving.Risky business: focus-group analysis of sexual behaviors, drug use and victimization among incarcerated women in St. Louis.Prevalence of hepatitis C infection in New York City, 2004Women in community corrections in New York City: HIV infection and risks.Prevalence of human immunodeficiency virus infection and associated risk factors among prison inmates in the City of Florianópolis.
P2860
Q24676385-818FE6AB-4D31-43BA-A3D1-AB6632712EE2Q26785981-3EFA2CAC-CAE6-41F6-8E84-CAE7D9D54EA0Q27481330-4B5DC86A-B3D9-4595-A460-FD2A75BE4CCCQ28079580-824D573E-FB8F-479E-B640-AF2C4B7C1A33Q33739154-9E8329B0-A611-481F-896E-41563DD378E6Q33777428-49BA36AB-226E-4229-9102-907B7DD7BE75Q34104877-A4A6EA21-08FB-4A68-B1C5-C8FC9A4A80CEQ34131004-6573073D-23DD-4919-BACB-3FE18DB37BB2Q34315023-7E9290EC-81CF-47BF-B2B0-35E4E7D66B4EQ34556215-0C32403E-C12C-4B12-B2F9-F85C500BABDBQ34620876-F22D0457-7D8B-4868-860E-08A65C3B3D4EQ34954320-D31E6B21-2989-4C81-BB89-329F0000823AQ35037688-AB680636-2C81-4EBB-9875-6DF74BF8FAB4Q35093629-60DD6F85-E453-40FA-AFFF-53F3C826F925Q35208581-5744B943-7B04-45A6-8992-F724733D726FQ35507204-5473DEEB-27EC-4616-8C84-F4469A38ADBDQ35564279-7B8DCE37-5C31-4517-91A0-44825076C1A3Q35606675-B17A4377-445C-4532-BAAD-A186CC71DDA6Q35670065-41DAE849-D585-478E-BBFA-1E731B25F0CEQ35699116-3DEC9988-FE02-4DDC-B752-5824320202DBQ35858448-6E94CF96-6A3E-42CC-A1FC-34184D25A6D3Q35908638-61A8DE1C-63DC-429E-9119-604F00647C15Q35938063-526E74CF-61ED-41D9-8AD1-DFD1249BF8FBQ36042246-55A59B6E-8E30-4DA3-A9D7-0F74475F3FEDQ36299963-89B0648C-17A2-4983-924E-831A11188BC5Q36454765-9EFC7D48-34AA-437D-B106-DE50AAB55B18Q36638429-6423FABC-1DFC-44C4-A7E8-D0A3E9EE0F0CQ36655273-5163C961-338D-42F1-AF75-295230C60BCEQ36821122-5283B0FD-FC3E-4C22-A22D-C91C3E88293DQ36856130-6AECA382-0857-4BD4-A358-A141B8F4E9C0Q36945751-5789E57C-2DD0-4D57-8D61-372F3AFB75B3Q37015123-47659A45-E0E9-40D0-BA4A-3375BD89BC45Q37034929-B847AFF6-D3A1-4E62-9B58-AA3A97C3B6BDQ37189427-33C536A7-81C7-429A-A797-CF00F618BAB9Q37191549-DC015C2C-60F5-4E27-A713-D855E6699092Q37299503-65F42424-61CE-4DF2-9BD5-48084FF22A7EQ37313096-60A8E982-7788-456C-B1F0-6AC104E85547Q37470465-30E4E061-1970-4B84-A1F5-7C8A52408953Q37723121-BDF665AC-3B11-4712-BE76-0030A19133C0Q39216343-DD16869A-26B1-4F7D-AB4E-5938C0D8D5BA
P2860
Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@ast
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@en
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@nl
type
label
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@ast
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@en
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@nl
prefLabel
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@ast
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@en
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@nl
P2093
P1433
P1476
Hepatitis B, hepatitis C, and ...... f epidemiology and prevention.
@en
P2093
Cindy M Weinbaum
Keith M Sabin
Scott S Santibanez
P356
10.1097/01.AIDS.0000192069.95819.AA
P407
P478
19 Suppl 3
P577
2005-10-01T00:00:00Z